Skip to main content

Leica Biosystems Aktuelles

Updates about Leica Biosystems.

csm_Leica_Biosystems
Published: 23 April 2021

NEW YORK, NY and VISTA, CALIF. – April 23, 2021 — Paige, a global leader in AI-based digital diagnostics, and Leica Biosystems, a globally recognized cancer diagnostics and workflow solution leader, today announced a strategic partnership to expand access to computational pathology…

210598_leica___cell_idx_banner_small
Published: 22 April 2021

Imagine the possibilities for your Chromogenic Multiplex with Leica Biosystems and Cell IDx To accelerate the discovery journey in cancer research, Leica Biosystems has partnered with Cell IDx, a technology leader in multiplexed cellular immunodiagnostics, developing highly sensitive and specific…

Published: 19 August 2020

Research-use-only RNA-ISH probes now available for COVID-19 on our automated platform Leica Biosystems, in partnership with Bio-Techne Corporation, announces the automation of RNAscope™ COVID-19 probes’ on BOND RX*, its staining platform, for research use only. Researchers now have the capability…

Leica_Biosystems_Digital_Pathology_Virtual_Summit_-_On-Demand_Presentations
Published: 11 August 2020

Leica Biosystems, a global leader in pathology workflow solutions, announced the European launch of its Aperio GT 450 DX digital pathology scanner. This next generation imaging system was unveiled at the highly successful Leica Biosystems Digital Pathology Virtual Summit and is already installed at…

Published: 12 May 2020

VISTA, CA May 12th, 2020 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450 DX, its next generation digital pathology scanner, in the APAC region. With continuous loading, no-touch operation, and 32 second scan time at 40x…

Published: 24 April 2020

VISTA, CA April 24, 2020 – Leica Biosystems, the global leader in pathology workflow solutions, today announced it has received additional notification from the U.S. Food & Drug Administration (FDA) about its intention to exercise enforcement discretion when the Aperio WebViewer, a web-based…

Published: 3 April 2020

VISTA, CA, April 3, 2020 – Leica Biosystems, the global leader in pathology workflow solutions, today announced it has received notification from the U.S. Food & Drug Administration ( FDA ) that its Aperio ImageScope DX Viewer with images acquired on the Aperio AT2 DX Scanner can be used for…

Leica_Biosystems_Logo_Card
Published: 2 March 2020

VISTA, Calif.—Mar 2, 2020—Leica Biosystems, a globally recognized cancer diagnostics and workflow solution leader, today announced a significant development for anatomical pathology laboratories by bringing together its Aperio AT2 DX System—digital pathology whole slide imaging—with Aperio Path DX…

Leica_Biosystems_Logo_Card
Published: 2 December 2019

VISTA, CA –December 2nd, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, and the international medical imaging IT and cybersecurity company, Sectra, announce a collaboration to seek a combined 510(k) clearance from the U.S. Food & Drug Administration (FDA) in the…

Published: 13 November 2019

International panel of pathologists drive forward-thinking agenda on role of pathology in transforming cancer diagnostics and improve patient care London, UK – Nov. 13, 2019. On International Pathology Day, Leica Biosystems, a world-leading cancer diagnostics company, today announced the launch of…